CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Galderma Laboratories LP v. Tolmar Inc.

1:10-cv-00045

Overview

Case Number 1:10-cv-00045
Filing Date 2010-01-21
Status Terminated
Termination Date 2012-09-24
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Actavis Mid Atlantic LLC Operating Company

Represented By

7 Attorneys Listed

Wesley O. Mueller

Email: wmueller@leydig.com

Steven H. Sklar

Email: ssklar@leydig.com

Lawrence Scott Beall

Email: sbeall@leydig.com

Jamaica P. Szeliga

Email: jszeliga@seyfarth.com

Gregory C. Bays

Email: gbays@leydig.com

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Tolmar Inc. Operating Company

Represented By

11 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Thomas P. Steindler

Email: tsteindler@mwe.com

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Peter M. Siavelis

UNDELIVERABLE EMAIL 6/13/2019

Lauren N. Martin

Email: laurenmartin@quinnemanuel.com

Krista Vink Venegas

UNDELIVERABLE EMAIL 6/13/2019

Kevin P. Shortsle

Email: KShortsle@HowardandHoward.com

Keith M. Stolte

UNDELIVERABLE EMAIL 6/14/2019

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Jeffrey R. Gargano

Email: jeffrey.gargano@morganlewis.com

Adam Wyatt Poff

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Plaintiff

Galderma Research and Development SNC Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Galderma SA NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Galderma Laboratories LP NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

Rebecca D. Hess

UNDELIVERABLE EMAIL 1/21/15

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Courtney B. Casp

Email: courtney.casp@finnegan.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 21 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (21): FR 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7579377
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Filed: 2004-09-10
Issued: 2009-08-25
Expired (Term Ended) +730d PTA
Expires: 2026-09-10
US7737181
Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Filed: 2006-07-28
Issued: 2010-06-15
Expired (Term Ended)
Expires: 2024-08-29
US7834060
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
Filed: 2009-05-07
Issued: 2010-11-16
Expired (Term Ended)
Expires: 2023-05-16
US7838558
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Filed: 2008-04-15
Issued: 2010-11-23
Active (1.4 yrs remaining)
Expires: 2028-04-15
US7868044
Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
Filed: 2010-05-03
Issued: 2011-01-11
Active (3.4 yrs remaining)
Expires: 2030-05-03

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+730 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 5/6/2011. Amended Pleadings due by 5/6/2011....
Entry #40 • 2011-02-15 Document →

Docket Entries

(60 total)
Pleading / Complaint

COMPLAINT filed against Tolmar Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-683143.) - filed by Galderma Laboratories LP, Galderma SA, Galderma Research and Development SNC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dmp, ) (Entered: 01/22/2010)

Entry #1 • 2010-01-21
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dmp, ) (Entered: 01/22/2010)

Entry #2 • 2010-01-21
1

Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories LP, Galderma Research and Development SNC, Galderma SA identifying Corporate Parent Galderma Pharma SA for Galderma SA; Corporate Parent Galderma International for Galderma Research and Development SNC; Other Affiliate Galderma General LLC, Other Affiliate Galderma Limited LLC for Galderma Laboratories LP. (dmp, ) (Entered: 01/22/2010)

Entry #3 • 2010-01-21
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,377 B2; (dmp, ) (Entered: 01/22/2010)

Entry #4 • 2010-01-22
1
Pleading / Complaint

SUMMONS Returned Executed by Galderma Laboratories LP, Galderma SA, Galderma Research and Development SNC. Tolmar Inc. served on 1/22/2010, answer due 2/12/2010. (Noreika, Maryellen) (Entered: 01/22/2010)

Entry #5 • 2010-01-22
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc